APC unveils €25m investment and 120 jobs to accelerate development and manufacture of Covid Vaccines and Advanced Therapeutics.
Industry Veteran Brett Huff has joined APC to head up our First-in-Class Digital Strategy for process development.
At APC, we’re very proud of the fact that we help companies accelerate the development of therapeutics for rare diseases.
APC welcomed Irish Prime Minister to discuss fast-tracking a COVID-19 vaccine with Australian firm Vaxine, showcasing our role in advancing vital medicines.
Irish R&D firm APC partners with Australian biotech Vaxine to speed up COVID-19 vaccine candidate development, accelerating the time to patients.
APC has joined the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) as one of the 26 industrial partners.
A Message from the APC Team to Collaborators, "Now, more than ever, collaboration is vital."
Collaboration between Takeda and APC will design, optimize and deliver process improvements for Takeda’s portfolio of biologics-based medicines.
APC Hosted a Complimentary Workshop in Partnership With Nucleo Life Sciences on Technology Innovations in API and Drug Product Formulation Development.
APC and NIBRT join forces, expanding client access to biopharmaceutical services, enhancing process development and analytical capabilities.